Svetlana Lucas's Net Worth

$0

Estimate Recalculated Sep 12, 2024 04:20PM EST

Who is Svetlana Lucas?

Svetlana Lucas does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include aTYR PHARMA INC, and Jasper Therapeutics, Inc..

SEC CIK

Svetlana Lucas's CIK is 0001781292

Past Insider Trading and Trends

2023 was Svetlana Lucas's most active year for acquiring shares with 2 total transactions. Svetlana Lucas's most active month to acquire stocks was the month of March. 2023 was Svetlana Lucas's most active year for disposing of shares, totalling 1 transactions. Svetlana Lucas's most active month to dispose stocks was the month of March. 2024 saw Svetlana Lucas paying a total of $0.00 for 39,000 shares, this is the most they've acquired in one year. In 2023 Svetlana Lucas cashed out on 6,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

aTYR PHARMA INC (LIFE) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 17
Form 4
∞
6K
—
—
6K
Apr 26
Form 4
—
0
—
—
0
Apr 26
Form 4
—
0
—
—
0
Apr 28
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
Jun 28
Form 3
—
0
—
—
0
No matching records found

Jasper Therapeutics, Inc. (JSPR) Snapshot price: $18.63

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 18
Form 3
—
0
—
—
0
No matching records found